Home > About > News > Story

News

2012-09-05 - Expect new COPD medications in the next couple years

Both GSK & Novartis are working on steroid-free, once-daily combination treatments known as LABA/LAMA drugs that promise improved patient compliance and disease control, while avoiding unnecessary exposure to steroids.